Search Results - "Goicochea Briceño, H"

Neurofilament light chain levels in pregnant multiple sclerosis patients: a prospective cohort study by Cuello, J. P., Martínez Ginés, M. L., Kuhle, J., García Domínguez, J. M., Lozano Ros, A., Romero Delgado, F., Higueras, Y., Meldaña Rivera, A., Goicochea Briceño, H., García‐Tizon Larroca, S., De León-Luis, J., Michalak, Z., Barro, C., Álvarez Lafuente, R., Medina Heras, S., Fernández Velasco, J. I., Tejeda‐Velarde, A., Domínguez‐Mozo, M. I., Muriel, A., de Andrés, C., Villar, L. M.

“…Background and purpose Neurofilament light chain is a cytoskeletal protein of neurons. Its levels are increasingly recognized as measures of neuroaxonal…”
Get full text

Recurrent intracranial hemorrhage in a patient with relapsing multiple sclerosis under interferon-β therapy by Sánchez-Soblechero, A., Cuello, J.P., Martínez Ginés, M.L., Lozano Ros, A., Romero Delgado, F., De Andrés, C., Goicochea Briceño, H., García Domínguez, J.M.

Get full text

Recurrent intracranial hemorrhage in a patient with relapsing multiple sclerosis under interferon-β therapy by Sánchez-Soblechero, A., Cuello, J.P., Martínez Ginés, M.L., Lozano Ros, A., Romero Delgado, F., De Andrés, C., Goicochea Briceño, H., García Domínguez, J.M.

Get full text

4CPS-104 Persistence with disease-modifying therapy in multiple sclerosis patients by Moraza, Á Narrillos, Martín Barbero, ML, Gomez Costas, D, Jose Manuel, GD, Martínez Ginés, ML, Goicochea Briceño, H, Pablo Cuello, J, Herranz Alonso, A, Sanjurjo Sáez, M

“…Background and importancePharmacists are well positioned to improve clinical outcomes for patients by assisting with individualised patient in the outpatient…”
Get full text

POSC26 Preferences Toward Attributes of Disease-Modifying Therapies: The Role of Nurses in Multiple Sclerosis Care (DECISIONS-MS STUDY) by Muñoz, B, Medrano, N, Azanza-Munárriz, C, Becerril-Ríos, N, Goicochea-Briceño, H, Horno, R, Lendínez-Mesa, A, Sánchez-Franco, C, Álvarez, C, Carreño, Á, Sarmiento, M, Bueno-Gil, G, Maurino, J

Get full text

PND144 - REPORTED QUALITY OF LIFE IN PEOPLE WITH MULTIPLE SCLEROSIS UNDER LONG TERM TREATMENT WITH FAMPRIDINE by Higueras, Y, Meldaña-Rivera, A., Goicochea-Briceño, H., García-Domínguez, J.M., Cuello, JP, Lozano-Ros, A., Martinez-Ginés, M.L.

Get full text

Periodic plasmapheresis as maintenance treatment in relapsing-remitting multiple sclerosis, a new therapeutic line? A case report by Lafuente-Gómez, G, Anaya-Fernández Lomana, F, Gómez-Roldós, A, García-Domínguez, J M, Lozano-Ros, A, Cuello, J P, Higueras-Hernández, Y, Meldaña-Rivera, A, Goicochea-Briceño, H, Leal-Hidalgo, R, De Miguel-Sánchez de Puerta, C J, Martínez-Ginés, M L

“…Relapsing-remitting multiple sclerosis (RRMS) treatment has significantly changed in recent years because of the discovery of new molecules that have shown…”
Get full text